| (Values in U.S. Thousands) | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2025 | Dec, 2025 |
| Sales | 230 | 260 | 160 | 0 | 0 |
| Sales Growth | -11.54% | +62.50% | unch | unch | unch |
| Net Income | -16,470 | -12,610 | -5,780 | 0 | 0 |
| Net Income Growth | -30.61% | -118.17% | unch | unch | unch |
Bionxt Solutions Inc (XPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
BioNxt Solutions Inc. is a bioscience accelerator focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations. BioNxt Solutions Inc., formerly known as XPhyto Therapeutics Corp., is based in VANCOUVER, BC.